Concepedia

Timothy Watson

TW

Statistics

Publications

8

Citations

210

H-Index

8

Active since

1994

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

AstraZeneca (United Kingdom)

Timothy Watson is an author at Pfizer (United States) specializing in pharmacy, chemistry, and natural sciences.

ORCID

Publications per year

1994–2018

8

Publications

8

API Quality by Design Example from the Torcetrapib Manufacturing Process

David J. am Ende, Karen S. Bronk, Jason Mustakis et al. · Journal of Pharmaceutical Innovation · 2007 · 52 citations

, , +10

A novel, efficient and general synthetic route to unsymmetrical triphenylene mesogens using palladium-catalysed cross-coupling reactions

John W. Goodby, Michael Hird, Kenneth J. Toyne et al. · Journal of the Chemical Society Chemical Communications · 1994 · 45 citations

, , +8

Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities

Joel P. Bercu, Susan C. Berlam, John C. Berridge et al. · Journal of Pharmaceutical Innovation · 2018 · 42 citations · Full text

, , +12

Synthesis of the kappa-agonist CJ-15,161 via a palladium-catalyzed cross-coupling reaction

Arun K. Ghosh, Janice E. Sieser, Stéphane Caron et al. · Chemical Communications · 2002 · 18 citations

, , +7

The Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategies

Stephen T. Colgan, Timothy Watson, Robert D. Whipple et al. · Journal of Pharmaceutical Innovation · 2012 · 16 citations

, , +13

1–5 of 8